2m 2m 2m 2m 2m 2m 2m
Evolutionary Gen (FNAM)
OTC
$0.0002$0.00 (0.00%)
Price as of Oct 31, 2025- N/AMarket Cap
- -75.00%1-Year Change
- BiotechnologyIndustry
Evolutionary Gen (FNAM)
$0.0002$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0002
$0.0002
$0.0002
1-Year Range
$0.0002
$0.0002
$0.0002
Latest Close$0.0002
Change
$0.00 (0.00%)
Volume1,000
Shares Outstanding6.7M
P/E (TTM)-1.50
Diluted EPS (TTM)-$0.30
Information as of 10/31/2025
Company Profile
EVOLUTIONARY GENOMICS, INC.
https://www.evolgen.comN/A
Market Cap
-$1.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
4220 Morning Star Drive, Castle Rock, CO, United States, 80108
303 513 3510Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. rice, corn, soybeans, wheat, cotton, cowpeas, beans, tomatoes, and cassava. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, cowpeas and cotton. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Key Executives
- Walter Messier
- Steve Warnecke
- Virginia Orndorff
Current Ownership Distribution
- Other4.3M (64.64%)
- Insiders2.4M (35.36%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)